JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.56, sa.3, ss.519-523, 2005 (SCI-Expanded, Scopus)
Objectives: We investigated vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneously vancomycin-intermediate S. aureus (hetero-VISA) isolates from clinical specimens of hospitalized patients at Hacettepe University over a 4 year period.